Global (United States, European Union and China) Neurovascular Embolization Devices Market Research Report 2019-2025
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Neurovascular Embolization Devices Quarterly Market Size Analysis
- 2.1 Neurovascular Embolization Devices Business Impact Assessment - COVID-19
- 2.1.1 Global Neurovascular Embolization Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Neurovascular Embolization Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Neurovascular Embolization Devices Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Neurovascular Embolization Devices Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Neurovascular Embolization Devices Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Neurovascular Embolization Devices Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Neurovascular Embolization Devices Market
- 3.5 Key Manufacturers Neurovascular Embolization Devices Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Neurovascular Embolization Devices Segments, By Type
- 4.1 Introduction
- 1.4.1 Embolization Coils
- 1.4.2 Flow Diversion Stents
- 1.4.3 Liquid Embolic Systems
- 1.4.4 Aneurysm Clips
- 4.2 By Type, Global Neurovascular Embolization Devices Market Size, 2019-2021
- 4.2.1 By Type, Global Neurovascular Embolization Devices Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Neurovascular Embolization Devices Price, 2020-2021
5 Impact of Covid-19 on Neurovascular Embolization Devices Segments, By Application
- 5.1 Overview
- 5.5.1 Hospitals
- 5.5.2 Clinics
- 5.5.3 Ambulatory Surgical Centers
- 5.2 By Application, Global Neurovascular Embolization Devices Market Size, 2019-2021
- 5.2.1 By Application, Global Neurovascular Embolization Devices Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Neurovascular Embolization Devices Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Medtronic
- 7.1.1 Medtronic Business Overview
- 7.1.2 Medtronic Neurovascular Embolization Devices Quarterly Production and Revenue, 2020
- 7.1.3 Medtronic Neurovascular Embolization Devices Product Introduction
- 7.1.4 Medtronic Response to COVID-19 and Related Developments
- 7.2 Stryker
- 7.2.1 Stryker Business Overview
- 7.2.2 Stryker Neurovascular Embolization Devices Quarterly Production and Revenue, 2020
- 7.2.3 Stryker Neurovascular Embolization Devices Product Introduction
- 7.2.4 Stryker Response to COVID-19 and Related Developments
- 7.3 Terumo
- 7.3.1 Terumo Business Overview
- 7.3.2 Terumo Neurovascular Embolization Devices Quarterly Production and Revenue, 2020
- 7.3.3 Terumo Neurovascular Embolization Devices Product Introduction
- 7.3.4 Terumo Response to COVID-19 and Related Developments
- 7.4 Johnson & Johnson
- 7.4.1 Johnson & Johnson Business Overview
- 7.4.2 Johnson & Johnson Neurovascular Embolization Devices Quarterly Production and Revenue, 2020
- 7.4.3 Johnson & Johnson Neurovascular Embolization Devices Product Introduction
- 7.4.4 Johnson & Johnson Response to COVID-19 and Related Developments
- 7.5 B. Braun Melsungen
- 7.5.1 B. Braun Melsungen Business Overview
- 7.5.2 B. Braun Melsungen Neurovascular Embolization Devices Quarterly Production and Revenue, 2020
- 7.5.3 B. Braun Melsungen Neurovascular Embolization Devices Product Introduction
- 7.5.4 B. Braun Melsungen Response to COVID-19 and Related Developments
- 7.6 Penumbra
- 7.6.1 Penumbra Business Overview
- 7.6.2 Penumbra Neurovascular Embolization Devices Quarterly Production and Revenue, 2020
- 7.6.3 Penumbra Neurovascular Embolization Devices Product Introduction
- 7.6.4 Penumbra Response to COVID-19 and Related Developments
- 7.7 Balt Extrusion
- 7.7.1 Balt Extrusion Business Overview
- 7.7.2 Balt Extrusion Neurovascular Embolization Devices Quarterly Production and Revenue, 2020
- 7.7.3 Balt Extrusion Neurovascular Embolization Devices Product Introduction
- 7.7.4 Balt Extrusion Response to COVID-19 and Related Developments
- 7.8 Integra LifeSciences
- 7.8.1 Integra LifeSciences Business Overview
- 7.8.2 Integra LifeSciences Neurovascular Embolization Devices Quarterly Production and Revenue, 2020
- 7.8.3 Integra LifeSciences Neurovascular Embolization Devices Product Introduction
- 7.8.4 Integra LifeSciences Response to COVID-19 and Related Developments
- 7.9 Acandis GmbH
- 7.9.1 Acandis GmbH Business Overview
- 7.9.2 Acandis GmbH Neurovascular Embolization Devices Quarterly Production and Revenue, 2020
- 7.9.3 Acandis GmbH Neurovascular Embolization Devices Product Introduction
- 7.9.4 Acandis GmbH Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Neurovascular Embolization Devices Supply Chain Analysis
- 8.1.1 Neurovascular Embolization Devices Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Neurovascular Embolization Devices Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Neurovascular Embolization Devices Distribution Channels
- 8.2.2 Covid-19 Impact on Neurovascular Embolization Devices Distribution Channels
- 8.2.3 Neurovascular Embolization Devices Distributors
- 8.3 Neurovascular Embolization Devices Customers
9 Key Findings
10 Appendix
- 10.1 About Us
This report covers market size and forecasts of Neurovascular Embolization Devices, including the following market information:
Global Neurovascular Embolization Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Neurovascular Embolization Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Neurovascular Embolization Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Neurovascular Embolization Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Medtronic, Stryker, Terumo, Johnson & Johnson, B. Braun Melsungen, Penumbra, Balt Extrusion, Integra LifeSciences, Acandis GmbH, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Embolization Coils
Flow Diversion Stents
Liquid Embolic Systems
Aneurysm Clips
Based on the Application:
Hospitals
Clinics
Ambulatory Surgical Centers